Literature DB >> 9255250

Renal oncocytoma: a clinicopathologic study of 70 cases.

B Perez-Ordonez1, G Hamed, S Campbell, R A Erlandson, P Russo, P B Gaudin, V E Reuter.   

Abstract

We reviewed 954 primary nonurothelial epithelial renal neoplasms with primary resection at Memorial Sloan-Kettering Cancer Center between the years 1980 and 1995 and classified 70 cases (7%) as renal oncocytomas. The study population was composed of 39 men and 31 women, and the mean age was 65 years (range 25 to 86 years). Fifty-six patients (80%) were asymptomatic at presentation, six (4%) had flank pain, six (4%) presented with a mass, and two (3%) had hematuria. Sixty-one were treated with total or radical nephrectomy, nine with partial nephrectomy. The right kidney was involved in 35 cases (50%), the left kidney in 32 (46%). Three cases (4%) were bilateral. Sixty-one cases (87%) were unifocal, nine (13%) multifocal. All the tumors were well circumscribed but unencapsulated. Forty-five (64%) were described as brown or red, whereas the remainder were variously described as tan to yellow. Central fibrosis or scar was described in 23 cases (33%), and gross areas of hemorrhage or cystic changes in 14 (20%). The mean size was 5.2 cm and median 5.0 cm (range 1.5 cm to 14 cm). Histologically, the tumors were characterized by a mixture of architectural patterns: compact cellular nests and acini embedded in a hyalinized, hypocellular stroma were present in 62 cases (89%), a solid nested architecture in 47 cases (67%), and a variable tubular component in 50 cases (71%). Small papillae, pseudopapillae, and intratubular epithelial tufts were seen in 19 cases (27%). Cytologically, the neoplasms also showed a mixture of cell types, the most common being the classic oncocyte, which consisted of round or polygonal cells with moderate to abundant granular, eosinophilic cytoplasm, and small round nuclei with evenly dispersed granular chromatin. Small basophilic nucleoli were visible in many of these cells in all cases. Thirty-one cases (44%) had a variable number of oncocytic cells with pyknotic nuclei and 20 (30%) contained clusters of small cells with a high nuclear/cytoplasmic ratio and dense hyperchromatic nuclei (so-called oncoblasts). Foci of tubules with clear cells embedded in a hyalinized stroma were present in six cases (9%). Cellular atypia was evident in 42 cases (60%) and was marked in 21 (30%). Eleven cases (16%) exhibited mitotic activity, albeit low. No case had atypical mitoses or necrosis. Twenty-two cases (31%) had areas of calcification within the hyalinized stroma, 12 (17%) had calcospherites, and three (4%) had osseous and myeloid metaplasia. Vascular invasion was present in three cases (4%), and invasion of perinephric fat in 14 (20%). One patient presented with liver metastasis. Fourteen cases (20%) were pT1, 42 (60%) pT2, and 14 (20%) pT3. After a mean follow-up of 58 months (range 1 to 181), 62 patients (89%) were alive with no evidence of tumor, six (9%) had died of other causes, one was alive with stable metastatic disease in the liver 58 months after diagnosis, and one died with metastatic disease to bone and liver. We conclude that renal oncocytomas have a varied morphologic appearance and their pathologic diagnosis should be based on a constellation of architectural and cytologic features. The overwhelming majority of cases behave in a benign fashion, although in rare instances they can metastasize. The presence of atypical morphologic features do not alter the excellent prognosis associated with oncocytomas and do not predict an aggressive clinical course.

Entities:  

Mesh:

Year:  1997        PMID: 9255250     DOI: 10.1097/00000478-199708000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  70 in total

1.  Multiple Synchronous Tumors in a Patient: A Rare Entity.

Authors:  Panteleimon Tsipas; Georgios Laoutides; Athanassios Archontakis; Dimitrios Sampaziotis; Christophoros Kotoulas
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Small-cell variant of renal oncocytoma with dominating solid growth pattern: a potential diagnostic pitfall.

Authors:  Gaetano Magro; Marina Paola Gardiman; Maria Rosa Lopes; Michal Michal
Journal:  Virchows Arch       Date:  2005-11-16       Impact factor: 4.064

3.  Multilocular cystic renal oncocytoma.

Authors:  X Leroy; S Aubert; L Lemaitre; J Haffner; J Biserte; B Gosselin
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

4.  Renal oncocytoma on 1-11C acetate positron emission tomography: Case report and literature review.

Authors:  Jabi Shriki; Venkatesh Murthy; Jeffrey Brown
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 5.  Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?

Authors:  Th Van der Kwast; B Perez-Ordoñez
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

Review 6.  Imaging of Solid Renal Masses.

Authors:  Fernando U Kay; Ivan Pedrosa
Journal:  Urol Clin North Am       Date:  2018-06-15       Impact factor: 2.241

7.  Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation--a diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases.

Authors:  O Hes; T Vanecek; D M Perez-Montiel; I Alvarado Cabrero; M Hora; S Suster; J Lamovec; R Curik; V Mandys; M Michal
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

Review 8.  Association of angiomyolipoma and oncocytoma of the kidney: a case report and review of the literature.

Authors:  K Pillay; J Lazarus; H C Wainwright
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 9.  Update on oncocytoma.

Authors:  Stephen M Schatz; Michael M Lieber
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

10.  BCA2 is differentially expressed in renal oncocytoma: an analysis of 158 renal neoplasms.

Authors:  Laleh Ehsani; Rishie Seth; Stephanie Bacopulos; Arun Seth; Adeboye O Osunkoya
Journal:  Tumour Biol       Date:  2012-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.